NeuroBo Pharmaceuticals, Inc

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRBO and other ETFs, options, and stocks.

About NRBO

NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. 

CEO
Ben Gil Price
CEOBen Gil Price
Employees
11
Employees11
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
11
Employees11

NRBO Key Statistics

Market cap
11.75M
Market cap11.75M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.16M
Average volume1.16M
High today
$13.90
High today$13.90
Low today
$12.52
Low today$12.52
Open price
$13.40
Open price$13.40
Volume
110.84K
Volume110.84K
52 Week high
$63.85
52 Week high$63.85
52 Week low
$0.2465
52 Week low$0.2465

NRBO Earnings

-$36.00
-$24.00
-$12.00
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, After Hours
ActualExpected Nov 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.